Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Porcine circovirus type 3 cap protein, nucleic acid, virus-like particle, vaccine, preparation method and application

A porcine circovirus and virus-like technology, applied in the field of molecular biology, can solve the problems of low VLP expression, complex production process, and high production cost, and achieve the goal of improving yeast expression efficiency, simple production process, and no endotoxin pollution Effect

Active Publication Date: 2022-05-31
天康制药股份有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the PCVcap protein expressed by Escherichia coli has low solubility and is polluted by endotoxin, and the endotoxin removal process in the later stage is complex and expensive; the VLP expressed by the insect baculovirus system has a good immune effect, but the insect baculovirus produced VLP expression is low, production cost is expensive, the production process is complicated, and it is difficult to produce large-scale production as an animal vaccine
As an efficient protein expression system, the yeast expression system has many advantages, but due to the influence of the PCV3 cap protein's own nuclear localization sequence, it is easy to form insoluble protein aggregation when directly expressing the protein, so the soluble expression of the PCV3 cap protein in the yeast system challenging

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Porcine circovirus type 3 cap protein, nucleic acid, virus-like particle, vaccine, preparation method and application
  • Porcine circovirus type 3 cap protein, nucleic acid, virus-like particle, vaccine, preparation method and application
  • Porcine circovirus type 3 cap protein, nucleic acid, virus-like particle, vaccine, preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0041] Preferably, the eukaryotic expression vector comprises pPICZɑA. Using pPICZɑA as the expression vector, it has transformation effect.

[0047] The present embodiment does not limit the method of purification, and conventional protein purification methods in the art can be used. preferably use

[0048] The present invention also provides a nucleic acid encoding the above-mentioned porcine circovirus type 3 Cap protein.

[0051] The term "identity" refers to the similarity between sequences. "Identity" includes SEQ ID as described in the present invention

Embodiment 1

Embodiment 2

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention provides a porcine circovirus type 3 Cap protein, nucleic acid, virus-like particles, vaccines and preparation methods and applications, and relates to the technical field of molecular biology. The porcine circovirus type 3 Cap protein provided by the invention has such as SEQ The protein with the amino acid sequence shown in ID NO.2 can be expressed solublely in a yeast expression system, and effectively improves the yeast expression efficiency of porcine circovirus type 3 Cap protein. Moreover, the porcine circovirus type 3 Cap protein provided by the present invention can be self-assembled into virus-like particles, and the vaccine prepared by using the virus-like particles has the characteristics of both cellular immunity and humoral immunity. Immunological related experiments show that the immune effect is very good. it is good. The use of yeast expression system to express porcine circovirus type 3 Cap protein has the advantages of low production cost, simple production process, a large amount of target protein can be obtained through high-density fermentation, and no endotoxin pollution, and can be used for large-scale production.

Description

Porcine circovirus type 3 Cap protein, nucleic acid, virus-like particle, vaccine and preparation method and application technical field The present invention relates to molecular biology technical field, relate in particular to a kind of porcine circovirus type 3 Cap protein, nucleic acid, Virus-like particle, vaccine and preparation method and application. Background technique Porcine circovirus (PCV) is a single-stranded circular DNA virus with a gene length of about 1.7kb, which is the smallest animal DNA disease One of the poisons, mainly causing multisystem collapse syndrome, pneumonia, dermatitis, nephrotic syndrome, reproductive disorders in piglets, Colonization brought heavy losses. PCV3 is a new type of circovirus, and there is no commercial vaccine against PCV3 in China. PCV3 and PCV2 The homology of the cap protein gene is very low, only 30% identical, which also implies that the existing PCV2 vaccine cannot protect pigs against immune Vulnerable t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/01C12N15/34C12N15/81A61K39/12A61P31/20C12R1/84
CPCC07K14/005C12N15/815A61K39/12A61P31/20C12N2750/10022C12N2750/10023C12N2750/10034C12N2800/22A61K2039/5258A61K2039/552
Inventor 贺笋郭苗苗张国庆闫鹏先肖升东李延涛王清华曾钰潘毅平
Owner 天康制药股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products